7-117590403-A-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_000492.4(CFTR):c.1730A>T(p.Tyr577Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFTR | NM_000492.4 | c.1730A>T | p.Tyr577Phe | missense_variant | Exon 13 of 27 | ENST00000003084.11 | NP_000483.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250312Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135438
GnomAD4 exome AF: 6.89e-7 AC: 1AN: 1451204Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 721826
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:4Benign:1Other:1
- -
- -
- -
This variant was identified in 1 patient with a clinically confirmed diagnosis of cystic fibrosis. The variant was classified in the context of a project re-classifying variants in the German Cystic Fibrosis Registry (Muko.e.V.). Link: https://www.muko.info/angebote/qualitaetsmanagement/register/cf-einrichtungen/mukoweb. Criteria applied: PM2_SUP, PM3_SUP, PP3, BP2, BS3_SUP -
- -
The p.Y577F variant (also known as c.1730A>T), located in coding exon 13 of the CFTR gene, results from an A to T substitution at nucleotide position 1730. The tyrosine at codon 577 is replaced by phenylalanine, an amino acid with highly similar properties. This mutation was reported in an individual with cystic fibrosis and was determined to be in cis with another CFTR variant, both of which were in trans (on different chromosomes) with p.F508del (Stuhrmann M et al. Clin. Genet., 1997 Oct;52:240-6). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
not provided Uncertain:1
The CFTR c.1730A>T; p.Tyr577Phe variant (rs39750828) is reported in the literature on the same chromosome as the c.1742dupT variant in an individual affected with cystic fibrosis that also carried the common pathogenic p.Phe508del variant (Stuhrmann 1997). While p.Tyr577Phe has also been reported in an individual with infertility without the linked c.1742dupT variant, it is not clear that the detection methods used in this study would have detected both variants (Morea 2005). The p.Tyr577Phe variant is reported on a single chromosome (1/250312 alleles) in the Genome Aggregation Database, indicating it is not a common polymorphism. The tyrosine at codon 577 is moderately conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. Computational analyses (Alamut v.2.11) predict that this variant may impact splicing by creating a novel cryptic acceptor splice site, although RNA analyses would be required to confirm this. Given the lack of clinical and functional data, the significance of the p.Tyr577Phe variant is uncertain at this time. References: Morea A et al. Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility. Mol Hum Reprod. 2005 Aug;11(8):607-14. Stuhrmann M et al. Detection of 100% of the CFTR mutations in 63 CF families from Tyrol. Clin Genet. 1997 Oct;52(4):240-6. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at